Vinge assisted in a large asset backed funding of consumer loans
November 11, 2009
Vinge assisted the lender and the arranger in connection with a Sweden based NOK 2.4 billion asset backed funding of consumer loans originated by Nordax Finans AB (publ). Vinge's team consisted of Henrik Ossborn, Magnus Bigner and Johan Ragnar.
Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
